Raaven Therapeutics AB

984500B02D95E114A729

This company holds an LEI

The code is maintained by another issuer. Moving it to us is free, and the annual fee is the same as everyone pays.

Issued today byUbisecure RapidLEI

559373-4063 · See the company record

The entity

Status: Active
LEI status: Issued and current
Category: Company
Legal form: Aktiebolag (XJHM)
Jurisdiction: Sweden
Entity created: January 27, 2022

Address

Country: Sweden
Legal address: Nils Forsbergsgatan 12217 54 MALMÖSweden (SE-M)

Identifier

LEI: 984500B02D95E114A729
Registered: September 10, 2024 at 04:26 PM UTC
Last updated: August 17, 2025 at 06:11 AM UTC
Next renewal: September 10, 2026 at 04:26 PM UTC
Issuer: Ubisecure RapidLEI (529900T8BM49AURSDO55)
Registered with: Companies Register (RA000544)
Identifier: 559373-4063
Verified against: Companies Register (RA000544)
Verified as: 559373-4063
Corroboration: Confirmed against a public register
GLEIF conformity: Does not meet the standard

Corporate structure

Why no parent is reported

No direct parent reportedNo ultimate parent reported: The parent has no LEI

Machine access

REST: https://lei.online/v1/entities/984500B02D95E114A729This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search